bioAffinity Technologies, Inc.
BIAF- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001712762
No open-market purchases or sales by bioAffinity Technologies, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $782.5K in total; no superinvestor holds it.
Other share classesBIAFW
Q3 2025 vs. Q2 2025
How the institutions holding bioAffinity Technologies, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 17 | 12 | −5 |
| Shares | 362.3K | 301.9K | −60.5K (−16.7%) |
| Value | $104.0K | $823.7K | +$719.7K (+691.7%) |
New holders (4)
Institutions that held bioAffinity Technologies, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 242,757 | $718.6K | 3.73% |
| Scientech Research LLC | 16,583 | $49.1K | 0.02% |
| Larson Financial Group LLC | 33 | $98 | 0.00% |
| FMR LLC | 26 | $77 | 0.00% |
Sold out (9)
Institutions that held bioAffinity Technologies, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Geode Capital Management, LLC | 125,459 | $36.0K |
| Captrust Financial Advisors | 27,885 | $8.01K |
| State Street Corp | 17,600 | $5.05K |
| XTX Topco Ltd | 15,598 | $4.48K |
| StoneX Group Inc. | 15,206 | $4.37K |
| Northern Trust Corp | 13,662 | $3.92K |
| Creative Planning | 12,095 | $3.47K |
| Sprott Inc. | 10,000 | $2.87K |
| Raymond James Financial Inc | 500 | $144 |